CD274 and cancer: Blockade of PD-L1 signaling on immune cells (especially DCs and macrophages) was demonstrated to be critical for an optimal anti-tumor immune response, as opposed to/in addition to cancer-cell intrinsic PD-L1 expression [55,56].